Biotech

All Articles

ArsenalBio raises $325M, turns off of previous lead property

.Toolbox Biosciences is moving on up. The tissue therapy business has added on $325 thousand in ammu...

Lilly- supported fat loss biotech reports IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana use medicine fails period 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's chances of protecting a fast, good selection on a $one hundred million option settlem...

ProKidney halts phase 3 trial certainly not required for tissue treatment permission

.ProKidney has quit among a set of stage 3 trials for its own tissue therapy for renal condition aft...

Vaxcyte climbs on 'stunning' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals referred to as "impressive" stage 1/2 records for its 31-valent...

Recursion's human brain ailment test reveals insufficient proof of efficacy

.Recursion has discovered by means of an early examination of its tech-enabled approach to medicine ...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Call it a situation of good chemistry: Acepodia, a biotech based upon Nobel Champion science, is pa...

Praxis epilepsy medication decreases seizures in period 2 hearing

.Practice Precision Medicines has scored yet another midphase gain in epilepsy this year, along with...

Three execs surrender as Dyne posts blended data for DMD applicant

.After leaving a medical grip several years back, Dyne Therapy has shown new phase 1/2 records for i...

Arrowhead fires off period 3 records in unusual metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its give in front of a prospective showdown with Ionis, releasi...